Showing papers by "Edward C. Taylor published in 1988"
•
07 Sep 1988TL;DR: Pyrido[2,3-d]pyrimidine compounds are prepared through the reaction of 2,4-diamino-6(1H)-pyrimidone and an activated derivative of a dialdehyde as discussed by the authors.
Abstract: Pyrido[2,3-d]pyrimidine compounds are prepared through the reaction of 2,4-diamino-6(1H)-pyrimidone and an activated derivative of a dialdehyde. A typical embodiment utilizes the dinitrile.
40 citations
••
23 citations
••
TL;DR: In this article, the palladium-catalyzed coupling of 2-pivaloyl-6-bromo-5-deazapterin with siyrene was used for the synthesis of 5-deaza analogues of folic acid.
23 citations
•
28 Jun 1988TL;DR: The diastereoisomeric forms of N-(4]-2-(2-amino-4-hydroxy-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-6-yl)ethyl]benzoyl)-L-glutamic acid are antineoplastic agents.
Abstract: The diastereoisomeric forms of N-(4-[2-(2-amino-4-hydroxy-5,6,7,8-tetrahydropyrido[2,3-d]-pyrimidin-6-yl)ethyl]benzoyl)-L-glutamic acid are antineoplastic agents. The compounds are prepared by separation of the diastereoisomeric form of the correspondingly protected glutamic derivatives and hydrolytic or hydrogenolytic removal of carboxylic acid and/or amino protecting groups. Typical embodiments are the (R,S) and (S,S) forms of N-(4-[2-(2-amino-4-hydroxy-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-6-yl)ethyl]benzoyl)-L-glutamic acid.
22 citations
••
TL;DR: A general method for the conversion of available pyrazine intermediates to 6,7-dihydrothieno[2,3-b] pyrazines and then to 6.7-dimethylrothienoi[3,2-g]pterins has been developed as a model synthetic strategy for an approach to Form B of the molybdenum cofactor as discussed by the authors.
Abstract: A general method for the conversion of available pyrazine intermediates to 6,7-dihydrothieno[2,3-b]pyrazines, and then to 6,7-dihydrothieno[3,2-g]pterins, has been developed as a model synthetic strategy for an approach to Form B of the molybdenum cofactor
18 citations
•
08 Aug 1988TL;DR: In this article, 2-amino-4-hydroxy-6-ethynylpyrido[2,3-d]pyrimidine and an ester of 4-iodobenzoic acid are prepared through the reaction of a halo-aromatic compound and an unsaturated compound in the prosence of a palladium catalyst.
Abstract: 2-Amino-4-hydroxy-6-[2-(4-carboxyphenyl)alk-1-en-1-yl]pyrido[2,3,-d]pyrimidines and 2-amino-4-hydroxy-6-[2-(4-carboxyphenyl)alk-1-yn-1-yl]pyrido[2,3-d]pyrimidines are prepared through the reaction of a halo-aromatic compound and an unsaturated compound in the prosence of a palladium catalyst. The products are chemical intermediates for the preparation of antineo-plastic agents. A typical embodiment is the reaction of a protected 2-amino-4-hydroxy-6-ethynylpyrido[2,3-d]pyrimidine and an ester of 4-iodobenzoic acid.
17 citations
••
TL;DR: In this article, the N 2 -pivaloyl methylthio-7 aza-6pterine avec le pyrrolidino-4' butene-3' yl-4 benzoate de methyle; apres desulfuration sur nickel de Raney.
Abstract: Reaction de la N 2 -pivaloyl methylthio-7 aza-6pterine avec le pyrrolidino-4' butene-3' yl-4 benzoate de methyle; apres desulfuration sur nickel de Raney, obtention de N 2 -pivaloyl didesaza-5,10 pteroate de methyle
15 citations
••
TL;DR: In this article, the intramoleculaire de Diels Alder de [tetrahydro-5,6,7,8 dimethyl-6,8 ω-alcynyloxy-3 ou ω alcynylamino-3] pyrimido [4,5] triazine-1,2,4diones-6.8
Abstract: Addition intramoleculaire de Diels Alder de [tetrahydro-5,6,7,8 dimethyl-6,8 ω-alcynyloxy-3 ou ω-alcynylamino-3] pyrimido [4,5-e] triazine-1,2,4diones-6,8
14 citations
••
TL;DR: In this paper, reaction des methylthio-7 aza-6lumazines et -pterines avec le pentyne-4ol-1, des butyne-3ols 1, l'hexyne-5ol-3 ou la butyne -3ylamine et cyclisation intramoleculaire des derives obtenus en furo-, pyranno- and pyrrolo [3,2-6,7] desaza-5pteridines
Abstract: Reaction des methylthio-7 aza-6lumazines et -pterines avec le pentyne-4ol-1, des butyne-3ols-1, l'hexyne-5ol-3 ou la butyne-3ylamine et cyclisation intramoleculaire des derives obtenus en furo-, pyranno- et pyrrolo [3,2-6,7] desaza-5pteridines
14 citations
••
TL;DR: This chapter discusses the syntheses of folic acid, aminopterin, and methotrexate analogs in which an intact L-glutamic acid side-chain is present while simultaneously varying the pteridine ring moiety, the C-9, N- 10 bridge and/or the benzoyl group.
Abstract: Publisher Summary This chapter discusses the syntheses of folic acid, aminopterin, and methotrexate analogs in which an intact L-glutamic acid side-chain is present while simultaneously varying the pteridine ring moiety, the C-9, N- 10 bridge and/or the benzoyl group. Several analogs of folic acid are known in which the only remaining structural feature of the folic acid molecule is the p-aminobenzoylglutamic acid moiety. Biological results are discussed in those cases where the analog has significant activity in tumor systems relative to methotrexate (MTX) or aminopterin (AP). Of the many classes of deazaFA derivatives investigated, none has received more attention or resulted in more promising candidate drugs than 5,8-dideaza (quinazoline) analogs. Methylation of folic acid (FA) with a 4-molar excess of methyl iodide gave a low yield of the tetramethyl derivative. A Dimroth rearrangement brought about by base at room temperature then gave hydrolysis of the methyl esters having taken place under the conditions of the rearrangement.
11 citations
••
••
TL;DR: A partir d'[oxo-3 pyrrolidino]-4 benzoates d'alkyle et d'amide d'acide cyano thioacetique, synthese d'alcoxycarbonyl-4' phenyl-6 amino-2 cyano-3 tetrahydro-3a,4,5,6 thieno [2,3-b] pyrroles as mentioned in this paper.
Abstract: A partir d'[oxo-3 pyrrolidino]-4 benzoates d'alkyle et d'amide d'acide cyano thioacetique, synthese d'alcoxycarbonyl-4' phenyl-6 amino-2 cyano-3 tetrahydro-3a,4,5,6 thieno [2,3-b] pyrroles. Etude RX du derive alcoxy=t-butoxy
••
TL;DR: In this article, an intramolecular Diels-Alder reaction of the in situ generated 3-(3-butynyl-thio)-6-carboethoxy-5-chloro-1,2,4-triazine (9) to provide the key intermediate 5-CARBOETHoxy-6-chloroxy-2,3-dihydrothieno-[2, 3-b]pyridine (6).
•
29 Jun 1988TL;DR: In this article, a protected derivative of N-[4-{1-hydroxy-3-(2-amino-4-hydroxpyrido[2,3-d]pyrimidin-6-yl)prop-2-en-2yl)benzoyl]glutamic acid and removal of the protecting groups are discussed.
Abstract: N-[4-{1-Hydroxy-3-(2-amino-4-hydroxy-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-6-yl)prop-2-yl )benzoyl]-glutamic acid, it salts, and derivatives thereof, have an inhibitory effect on one or more enzymes which utilize folic acid and can be used, alone or in combination, to inhibit the growth of those neoplasms which otherwise depend upon the enzymes so inhibited. The compounds can be prepared through catalytic hydrogenation of a protected derivative of N-[4-{1-hydroxy-3-(2-amino-4-hydroxy-pyrido[2,3-d]pyrimidin-6-yl)prop-2-en-2-yl)benzoyl]glutamic acid and removal of the protecting groups.
••
••
••
••
••
••
TL;DR: In this paper, it was shown that substitution of oxime ethers for nitriles on the dienophilic sidechains of the respective Diels-Alder precursors failed to increase their inverse electron demand.
Abstract: - 3-(2'-Cyanophenoxy)-1,2,4-triazines and 7-(2'-cyanophenoxy)-6-azalumazines undergo intramolecular Diels-Alder reactions to yield novel polycyclic pyrazines and lumazines. However, the analogous 5-(2'-cyanophenoxy)-1,2,4-triazines fail to undergo cycloaddition, preventing access to the unknown benzfuro[2,3- e ]-1,2,4-triazine system. Substitution of oxime ethers for nitriles on the dienophilic sidechains of the respective Diels-Alder precursors failed to increase their inverse electron demand Diels-Alder reactivity.